Denis Drygin

Denis Drygin

Company: Regulus Therapeutics

Job title: Chief Scientific Officer

Seminars:

Exploring the Role of MicroRNA in Genetic Kidney Disease Pathologies 9:00 am

Analyzing small non-coding RNAs involvement in post-transcriptional gene regulation Targeting of MicroRNA21 and MicroRNA17 as a therapeutic strategy for the treatment of Alport Syndrome and ADPKD Beyond Alport Syndrome and ADPKD: examining opportunities for MicroRNAs in FSGS, ARPKD and IgA nephropathyRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.